Rigel Pharmaceuticals Inc

RIGL

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001034842

SEC filings (opens in a new tab)

No open-market purchases or sales by Rigel Pharmaceuticals Inc insiders were filed in the last 90 days; 155 institutions reported holding it in 13F filings for Q2 2026, worth $640.4M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Rigel Pharmaceuticals Inc changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of RIGL: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	91	2	93	+4
Shares	10.4M	1.51M	11.9M	+3.03M (+34.1%)
Value	$85.4M	$12.4M	$192.6M	+$119.6M (+164.0%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (22)

Institutions that held Rigel Pharmaceuticals Inc at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to RIGL in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	1,561,443	$25.3M	0.00%
Assenagon Asset Management S.A.	441,765	$7.15M	0.01%
CM Management, LLC	290,000	$4.69M	3.74%
Nuveen Asset Management, LLC	115,163	$1.86M	0.00%
Goldman Sachs Group Inc	46,113	$746.1K	0.00%
State of Wisconsin Investment Board	28,860	$467.0K	0.00%
Lazard Asset Management LLC	20,012	$323.0K	0.00%
PDT Partners, LLC	19,914	$322.2K	0.03%
Hillsdale Investment Management Inc.	18,600	$300.9K	0.02%
Jump Financial, LLC	15,285	$247.3K	0.01%
Empire Financial Management Company, LLC	14,250	$230.6K	0.07%
Franklin Resources Inc	12,766	$193.0K	0.00%
Occudo Quantitative Strategies LP	10,389	$168.1K	0.03%
Globeflex Capital L P	9,200	$148.9K	0.01%
UBS Group AG	9,176	$148.5K	0.00%
Catalyst Funds Management Pty Ltd	2,700	$43.7K	0.01%
Farther Finance Advisors, LLC	667	$10.8K	0.00%
Allspring Global Investments Holdings, LLC	119	$1.93K	0.00%
GAMMA Investing LLC	54	$874	0.00%
Sterling Capital Management LLC	26	$421	0.00%
Loring Wolcott & Coolidge Fiduciary Advisors LLP	3	$39	0.00%
Capital Performance Advisors LLP	2	$32	0.00%

Sold out (18)

Institutions that held Rigel Pharmaceuticals Inc at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of RIGL in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Healthcare of Ontario Pension Plan Trust Fund	135,920	$1.12M
Gsa Capital Partners LLP	90,245	$742.0K
Millennium Management LLC	42,467	$349.1K
Zacks Investment Management	39,016	$320.7K
Prudential Financial Inc	33,924	$278.9K
XTX Topco Ltd	28,515	$234.4K
HRT Financial LP	27,687	$227.0K
Qube Research & Technologies Ltd	17,667	$145.2K
Ground Swell Capital, LLC	17,094	$140.5K
Citadel Advisors LLC	16,208	$133.2K
State of Wyoming	11,029	$90.7K
The PNC Financial Services Group, Inc.	1,034	$8.50K
Principal Securities, Inc.	211	$1.73K
Nelson, Van Denburg & Campbell Wealth Management Group, LLC	126	$1.03K
Simplex Trading, LLC	136	$1.00K
IFP Advisors, Inc	1,000	$807
Mather Group, LLC.	450	$666
Abich Financial Wealth Management LLC	24	$197

Not filed for Q3 2024 yet (2)

Institutions that held Rigel Pharmaceuticals Inc at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RIGL in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	1,512,899	$12.4M
Institutional & Family Asset Management, LLC	10	$82